The Antibody Lab
Private Company
Total funding raised: $800K
Overview
The Antibody Lab is a private, Vienna-based service provider focused on custom antibody development. Founded in 2007, it serves a global clientele in research, diagnostics, and therapeutic discovery by generating tailored antibodies. As a contract research organization (CRO) in the biologics space, its business model is built on fee-for-service projects, placing it in the 'Revenue Generating' stage. The company's success hinges on its technological capabilities, client relationships, and the sustained demand for high-quality antibody reagents.
Technology Platform
Integrated platform for custom antibody generation, likely combining hybridoma technology with phage/yeast display libraries for immunization, screening, selection, and engineering of monoclonal antibodies.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
The Antibody Lab operates in a highly competitive CRO market for antibody services. It competes with large international players like GenScript, Bio-Rad, and Abcam's service divisions, as well as numerous specialized SMEs and academic core facilities. Differentiation is achieved through customized service, scientific expertise, and niche capabilities rather than scale.